The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-sulfamoylphenylcarbamothioyl)dodecanamide ID: ALA2298029
PubChem CID: 4332085
Max Phase: Preclinical
Molecular Formula: C19H31N3O3S2
Molecular Weight: 413.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCC(=O)NC(=S)Nc1ccc(S(N)(=O)=O)cc1
Standard InChI: InChI=1S/C19H31N3O3S2/c1-2-3-4-5-6-7-8-9-10-11-18(23)22-19(26)21-16-12-14-17(15-13-16)27(20,24)25/h12-15H,2-11H2,1H3,(H2,20,24,25)(H2,21,22,23,26)
Standard InChI Key: KMRDXSMLSSULCJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 27 0 0 0 0 0 0 0 0999 V2000
33.8028 -18.4286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5090 -18.0173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2182 -18.4232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5059 -17.2001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9244 -18.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6336 -18.4179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9213 -17.1948 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.3398 -18.0066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0450 -18.4143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7507 -18.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7481 -17.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0339 -16.7799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3311 -17.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4537 -16.7735 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
40.1635 -17.1785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0395 -16.0632 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.8566 -16.0632 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0936 -18.0226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3874 -18.4339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6782 -18.0280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9720 -18.4392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9751 -19.2564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6843 -19.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3905 -19.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0997 -19.6570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8059 -19.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5151 -19.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
5 6 1 0
5 7 2 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
11 14 1 0
14 15 1 0
14 16 2 0
14 17 2 0
1 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.61Molecular Weight (Monoisotopic): 413.1807AlogP: 4.07#Rotatable Bonds: 12Polar Surface Area: 101.29Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.23CX Basic pKa: ┄CX LogP: 5.06CX LogD: 5.06Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.35Np Likeness Score: -1.43
References 1. Saeed A, Zaib S, Pervez A, Mumtaz A, Shahid M, Iqbal J. (2013) Synthesis, molecular docking studies, and in vitro screening of sulfanilamide-thiourea hybrids as antimicrobial and urease inhibitors, 22 (8): [10.1007/s00044-012-0376-4 ]